Form 10-Q - Quarterly report [Sections 13 or 15(d)]

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: July 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______to _______

Commission File Number 333-185928

ARAX HOLDINGS CORP.
(Exact name of registrant as specified in its charter)

Nevada		99-0376721
(State or other jurisdiction of Incorporation or organization)		(IRS Employer Identification No.)

820 E Park Ave, Blvd D200
Tallahassee, Florida 32301
(850) 254-1161

(Issuer’s telephone number including area code)

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

State the number of shares outstanding of each of the issuer’s classes of common equity as of the latest practicable date. As of September 20, 2024, there were 128,376,886 common shares outstanding.

Arax Holdings Corp.

TABLE OF CONTENTS

PART 1 – FINANCIAL INFORMATION	3

Item 1. – Financial Statements	3

Condensed Consolidated Balance Sheets as of July 31, 2024, (unaudited), and October 31, 2023 (as restated)	3

Condensed Consolidated Statements of Operations for the three and nine months ended July 31, 2024 and 2023 (as restated) (unaudited)	4

Condensed Consolidated Statement of Stockholders' Equity for the three and nine months ended July 31, 2024 and (as restated) 2023 (unaudited)	5

Condensed Consolidated Statements of Cash Flows for the nine months ended July 31, 2024 and 2023 (as restated) (unaudited)	6

Notes to Condensed Consolidated Financial Statements (unaudited)	7

Item 2. – Management’s Discussion and Analysis of Financial Condition And Results of Operations	24

Item 3. – Quantitative and Qualitative Disclosures about Market Risk	28

Item 4. – Controls and Procedures	28

Item 5. – Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	30

PART II - OTHER INFORMATION	31

Item 1A. – Risk Factors	31

Item 3. – Defaults Upon Senior Securities	31

Item 6. – Exhibits	31

SIGNATURES	32

ARAX HOLDINGS CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS

PART 1 – FINANCIAL INFORMATION

Item 1. – Financial Statements

	(unaudited)			(restated)
	July 31, 2024			October 31, 2023
ASSETS

Cash	$	12,169		$	1,448,769
Accounts receivable		755,587			226,951
Total current assets		767,756			1,675,720

Property and equipment, net of accumulated depreciation of $532 and $79, respectively		1,057			1,510
Capitalized software development costs		6,405,952			5,033,332
Other assets		169,373			169,373
Intangible assets, net		268,000			268,000
Total assets	$	7,612,138		$	7,147,935

LIABILITIES & STOCKHOLDERS’ DEFICIT

Accounts payable	$	137,223		$	100,000
Accrued expenses		200,910			100,378
Due to related party		157,756			157,756
Notes payable		11,000			—
Total current liabilities		506,889			358,134
Total liabilities		506,889			358,134

Commitments and contingencies (Note 10)

Stockholders’ equity:
Preferred Stock Series A, par value $0.001, 10,000,000 shares authorized, 10,000,000 shares issued and outstanding as of July 31, 2024 and October 31, 2023, respectively		10,000			10,000
Common stock, Par Value $0.0001, 950,000,000 shares authorized, 128,253,557 and 126,160,534 issued and outstanding as of July 31, 2024 and October 31, 2023		12,825			12,616
Common stock to be issued		900,000			1,440,000
Additional paid in capital		29,682,169			27,920,998
Accumulated deficit		(23,499,745	)		(22,593,813	)
Total stockholders’ equity		7,105,249			6,789,801
Total liabilities and stockholders’ equity	$	7,612,138		$	7,147,935

The accompanying notes are an integral part of these unaudited condensed financial statements.

ARAX HOLDINGS CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)


				(Restated)						(Restated)
	Three months			Three months			Nine months			Nine months
	Ended			Ended			Ended			Ended
	July 31,			July 31,			July 31,			July 31,
	2024			2023			2024			2023

Revenue	$	—		$	228,518		$	528,636		$	682,290
Cost of revenue		—			—			—			—
Gross Profit (Loss)		—			228,518			528,636			682,290

Operating expenses:
General and administrative expenses		329,765			2,836,560			608,904			3,853,913
Stock based compensation		—			—			721,861			1,959,107
Total Operating Expenses		329,765			2,836,560			1,330,765			5,813,020

LOSS FROM OPERATIONS		(329,765	)		(2,608,042	)		(802,129	)		(5,130,730	)

OTHER INCOME (EXPENSE):
Loss on short-term borrowing settlement		(103,400	)		—			(103,400	)		—
Other Income (Expense)		(101	)		334,743			(403	)		(750	)
Total Other Income (Expense)		(103,501	)		334,743			(103,803	)		(750	)

Net loss before taxes		(433,266	)		(2,273,299	)		(905,932	)		(5,131,480	)
Income tax provision (benefit)		—			—			—			—
Net loss	$	(433,266	)	$	(2,273,299	)	$	(905,932	)	$	(5,131,480	)

Net loss per share, basic and diluted	$	(0.00	)	$	(0.02	)	$	(0.01	)	$	(0.10	)
Weighted average shares outstanding, basic and diluted		128,066,699			114,065,825			127,256,650			50,007,263

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ARAX HOLDINGS CORP.
(restated)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
FOR THE THREE AND NINE MONTHS ENDED JULY 31, 2024 AND 2023
(unaudited)


	Preferred Stock				Common Stock				Common Stock to be Issued			Additional Paid		Accumulated			Total
	Shares		Amount		Shares		Amount		Amount			In Capital		Deficit			Equity
Balance as of October 31, 2023 (restated)		10,000,000	$	10,000		126,160,534	$	12,616	$	1,440,000		$	27,920,998	$	(22,593,813	)	$	6,789,801
Issuance of common stock for services		—		—		611,747		62		—			721,800		—			721,862
Reduction of common stock to be issued for acquisition		—		—		544,150		54		(360,000	)		359,946		—			—
Net Loss		—		—		—		—		—			—		(685,994	)		(685,994	)
Balance as of January 31, 2024 (restated)		10,000,000		10,000		127,316,431		12,732		1,080,000			29,002,744		(23,279,807	)		6,825,669
Issuance of common stock upon conversion of convertible notes		—		—		164,709		16		—			95,359		—			95,376
Reduction of common stock to be issued for acquisition		—		—		272,075		27		(180,000	)		179,973		—			—
Net Loss		—		—		—		—		—			—		213,328			213,328
Balance as of April 30, 2024		10,000,000		10,000		127,753,215		12,775		900,000			29,278,076		(23,066,479	)		7,134,372
Issuance of common stock upon conversion of convertible notes		—		—		390,342		39		—			256,704		—			256,743
Issuance of common stock upon settlement of short-term borrowings		—		—		110,000		11		—			147,389		—			147,400
Net Loss		—		—		—		—		—			—		(433,266	)		(433,266	)
Balance as of July 31, 2024		10,000,000	$	10,000		128,253,557	$	12,825	$	900,000		$	29,682,169	$	(23,499,745	)	$	7,105,249


	Preferred Stock				Common Stock				Common Stock to be Issued			Additional Paid		Accumulated			Total
	Shares		Amount		Shares		Amount		Amount			In Capital		Deficit			Equity
Balance as of October 31, 2022		10,000,000	$	10,000	$	10,335,294	$	1,034	$	—		$	684,046	$	(879,006	)	$	(183,926	)
Net Loss		—		—		—		—		—			—		(1,066,865	)		(1,066,865	)
Balance as of January 31, 2023		10,000,000		10,000		10,335,294		1,034		—			684,046		(1,945,871	)		(1,250,791	)
Issuance of common stock for acquisition		—		—		90,215,096		9,022		3,222,000			14,768,978		—			18,000,000
Issuance of common stock upon conversion of convertible promissory notes		—		—		4,250,173		425		—			1,100,041		—			1,100,466
Common stock issued for services		—		—		2,038,744		204		3,143			1,955,761		—			1,959,108
Issuance of common stock in the conversion of convertible notes related to the acquisition		—		—		2,619,875		262		27,626			522,397		—			550,285
Net Loss		—		—		—		—		—			—		(1,791,316	)		(1,791,316	)
Balance as of April 30, 2023		10,000,000		10,000		109,459,182		10,946		3,252,769			19,031,223		(3,737,187	)		18,567,751
Issuance of common stock upon conversion of convertible promissory notes		—		—		5,264,352		526		30,000			2,799,776		—			2,830,302
Common stock issued for acquisition		—		—		2,847,381		285		(1,812,769	)		1,812,484		—			—
Net Loss		—		—		—		—		—			—		(2,273,299	)		(2,273,299	)
Balance as of July 31, 2023 (restated)		10,000,000	$	10,000	$	117,570,915	$	11,757	$	1,470,000		$	23,643,483	$	(6,010,486	)	$	19,124,754

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ARAX HOLDINGS CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)


	For the nine months ended
	July 31, 2024			July 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES				(restated)
Net loss	$	(905,932	)	$	(5,131,480	)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of short-term borrowings		103,400			—
Depreciation and amortization expense		453			—
Noncash interest expense		377			—
Amortization of debt discount related to derivatives		—			1,047,879
Stock based compensation expense		721,862			1,959,095
Change in fair value of derivative liability		—			(1,047,879	)
Changes in operating assets and liabilities
Increase in accounts receivable		(528,636	)		(680,658	)
Increase in accounts payable and accrued liabilities		138,496			135,033
Net cash used in operating activities		(469,980	)		(3,718,010	)

CASH FLOWS FROM INVESTING ACTIVITIES
Capitalized software and development costs		(1,372,620	)		—
Net cash used in investing activities		(1,372,620	)		—

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		362,000			3,718,010
Proceeds from short-term borrowings		44,000			—
Net cash provided by financing activities		406,000			3,718,010

Net decrease in cash and cash equivalents		(1,436,600	)		—
Cash and cash equivalents, beginning of the period		1,448,769			—
Cash and cash equivalents, end of the period	$	12,169		$	—

Supplemental disclosures for cash flow information:
Cash paid during the period for interest		—			—

Supplemental disclosure of Noncash financing activities:
Issuance of common stock for acquisition of Core Business Holdings		—			14,778,000
Reduction of common stock to be issued for acquisition of Core Business Holdings		540,000			1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition of Core Business Holdings		—			522,659
Issuance of common stock upon conversion of convertible notes		352,118			3,781,478
Issuance of common stock upon settlement of debt		147,400			—
Purchase of intangible assets related to the Cilandro acquisition		—			268,000
Issuance of common stock for intangible assets related to the Cilandro acquisition		—			110,000

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ARAX HOLDINGS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
JULY 31, 2024 AND 2023
(unaudited)

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

General

Arax Holdings Corp. (“the Company”) is a Nevada corporation incorporated on February 23, 2012.

The Company currently has operations from a growing business in the software development and integration marketplace.

Management intends to explore and identify business opportunities within North America, Europe, Asia and Africa including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. Our executives have experience in business consulting, although no assurances can be given that they can identify and implement a viable business strategy or that any such strategy will result in profits. Our ability to effectively identify, develop and implement a viable plan for our business may be hindered by risks and uncertainties which are beyond our control, including without limitation, the continued negative effects of the coronavirus pandemic on the U.S. and global economies.

Principles of Consolidation and Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended October 31, 2023, filed with the SEC. In the opinion of management, the accompanying condensed financial statements contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of July 31, 2024, and the results of its operations and its cash flows for the nine months ended July 31, 2024 and 2023. The balance sheet as of October 31, 2023 (as restated), is derived from the Company’s audited financial statements. The results of operations for the three and nine months ended July 31, 2024, are not necessarily indicative of the results of operations to be expected for the full fiscal year ending October 31, 2024.

The condensed consolidated financial statements include the accounts of Arax Holdings Corp. and its wholly owned subsidiaries, Core Business Holdings and Cilandro SA. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results and outcomes may differ from management’s estimates and assumptions. Included in these estimates are assumptions used to estimate collection of accounts receivable, fair value of intangible assets, fair value of capitalized software, deferred income tax asset valuation allowances.

Cash

The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has not experienced any losses related to these balances as of July 31, 2024. The Company had no cash equivalents as of July 31, 2024.

Revenue Recognition

The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied. We generate revenue from the following activities:

The Company provides a range of services through various formats, including subscription-based access to browser-based software platforms. These platforms facilitate interactions between customers, enterprise clients, and other entities, utilizing blockchain technology for secure and transparent transactions.

●

Service Offerings: Include software subscriptions that require secure access, enabling user interactions via blockchain networks

●

Use Cases: The Company develops tailored solutions, known as Use Cases, which can incorporate both physical inventory and software components. These are customized for each client

●

Cost Sharing: In some instances, the Company co-invests in the initial setup infrastructure costs with government or enterprise partners

●

Revenue Model: Primarily, revenue is derived from subscription fees and transaction fees associated with blockchain interactions, rather than from the initial infrastructure investments

Contract Assets

The Company does not have any contract assets. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.

Cost of Revenues

Cost of revenues consists of employee costs, third party staffing costs and other fees, outsourced recruiter fees, and commissions. There have been no costs of revenue for the periods presented.

Accounts Receivable

On November 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make the required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.

Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Any required allowance is based on specific analysis of past due accounts and also considers historical trends of write-offs. Past due status is based on how recently payments have been received from customers. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. We have recorded no allowance for doubtful as of July 31, 2024 and October 31, 2023.

Property and Equipment

Property and equipment is stated at cost, less accumulated depreciation. Depreciation is recognized over an asset’s estimated useful life using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment to determine whether events or changes in circumstances warrant a revision to the remaining periods of depreciation. Maintenance and repairs are charged to expense as incurred. Depreciation expense for the three months ended July 31, 2024 and 2023 was $151 and $0, respectively and was $453 and $0 for the nine months ended July 31, 2024 and 2023, respectively.

Concentration of Credit Risk and Significant Customers and Vendors

As of July 31, 2024, and October 31, 2023 one customer accounted for all of the accounts receivable balance.

Research and Development

The Company expenses internal and external research and development costs, including costs of funded research and development arrangements, in the period incurred. The Company has no material research and development costs during the three and nine months ended July 31, 2024 and 2023, respectively.

Advertising and Marketing Costs

The Company expenses all advertising and marketing costs as incurred. Advertising and marketing costs were not material for the three and nine months ended July 31, 2024 and 2023, respectively.

Fair Value of Financial Instruments and Fair Value Measurements

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a hierarchical framework for measuring fair value, and enhances fair value measurement disclosure.

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The Company’s investment in available for sale securities and warrant derivative liabilities are measured at fair value. The securities are measured based on current trading prices using Level 1 fair value inputs. The Company’s derivative instruments are valued using Level 3 fair value inputs. In fair valuing these instruments, the income valuation approach is applied, and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The carrying values of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and loans payable represent fair value based upon their short-term nature.

A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The tables below summarize the fair values of our financial assets and liabilities as of July 31, 2023.

For the Company’s derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balance for each category therein, and gains or losses recognized during the nine months ended July 31, 2023:


Ending balance, October 31, 2022	$	—
Initial recognition of derivative liability:		1,047,879
Re-measurement adjustments:
Change in fair value of derivative liability		(1,047,879	)
Ending balance, July 31, 2023	$	—

The fair value of the derivative liability was estimated using binomial option-pricing model with the following assumptions:

	July 31, 2023
Stock Price on Valuation Date	$	0.70
Risk-Free Rate		5.53	%
Volatility		307.56	%
Term		2.5 yrs
Conversion price	$	0.2

Business Combinations

The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether or not the Company has acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is a business combination or an acquisition of assets.

Acquisitions meeting the definition of business combinations are accounted for using the acquisition method of accounting, which requires that the purchase price be allocated to the net assets acquired at their respective fair values. In a business combination, any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.

Intangible Assets

The Company has intangible assets with indefinite useful lives obtained as a result of assets acquisitions from Cilandro SA (see Note 6) in the second quarter of 2023, which includes financial license in aggregate amount of $268,000.

The Company does not amortize its intangible assets with indefinite useful lives, rather such assets are tested for impairment are tested for impairment annually, or more frequently if events or changes in circumstances indicate the asset may be impaired in accordance with ASC 350 Intangibles-Goodwill and Other. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.

Long-lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. The Company periodically evaluates whether events and circumstances have occurred that indicate possible impairment. When impairment indicators exist, the Company estimates the future undiscounted net cash flows of the related asset or asset group over the remaining life of the asset in measuring whether the long-lived asset should be written down to fair value. Measurement of the amount of impairment would be based on generally accepted valuation methodologies, as deemed appropriate. If the carrying amount is greater than the undiscounted cash flows, the carrying amount of the asset is reduced to the asset’s fair value. An impairment loss is recognized immediately as an operating expense in the condensed consolidated statements of operations. Reversal of previously recorded impairment losses are prohibited.

Software Development Costs

The costs incurred for the development of computer software to be sold, leased, or otherwise marketed are capitalized in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed, when technological feasibility has been established. Technological feasibility generally occurs when all planning, design, coding, and testing activities are completed that are necessary to establish that the product can be produced to meet its design specifications, including functions, features, and technical performance requirements. The establishment of technological feasibility is an ongoing assessment of judgment by management with respect to certain external factors, including, but not limited to, anticipated future revenues, estimated economic life, and changes in technology. Capitalized software includes direct and contracted labor and related expenses for software development for new products and enhancements to existing products and acquired software.

The Company does not amortize its software development costs with indefinite useful lives, rather such assets are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies at each balance sheet date. In the event of impairment, unamortized capitalized software costs are compared to the net realizable value of the related product and the carrying value of the related assets are written down to the net realizable value to the extent the unamortized capitalized costs exceed such value. The net realizable value is the estimated future gross revenues from the related product reduced by the estimated future costs of completing and disposing of such product, including the costs of providing related maintenance and customer support.

Related Party Transactions

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to the related party.

The Company considers all officers, directors, senior management personnel, and senior level consultants to be related parties to the Company.

Income Taxes

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not to be sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties, if any, related to income tax matters in income tax expense.

Stock-Based Compensation

We account for our stock-based compensation under ASC 718 “Compensation - Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the shorter of the service period or the vesting period of the stock-based compensation. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of October 31, 2023, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described. There was no derivative liability as of July 31, 2024 and October 31, 2023.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.

ASC 480 “Distinguishing Liabilities From Equity” provides that instruments convertible predominantly at a fixed rate resulting in a fixed monetary amount due upon conversion with a variable quantity of shares (“stock settled debt”) be recorded as a liability at the fixed monetary amount.

ASC 815 “Derivatives and Hedging” generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.

Leases

In February 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-02: “Leases (Topic 842)” whereby lessees need to recognize almost all leases on their balance sheet as a right of use asset and a corresponding lease liability. The Company adopted this standard as of January 1, 2019, using the effective date method and applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected not to reassess the following: (i) whether any expired or existing contracts contain leases, and (ii) initial direct costs for any existing leases. For contracts entered into after the effective date, at the inception of a contract the Company will assess whether the contract is, or contains, a lease. The Company’s assessment will be based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. The Company has elected not to recognize right of use assets and lease liabilities for short term leases that have a term of 12 months or less. As of July 31, 2024 and October 31, 2023 the Company did not have leases that qualified as right of use assets.

Loss per Share

The Company follows ASC 260 “Earnings Per Share” for calculating the basic and diluted earnings (or loss) per share. Basic earnings (or loss) per share are computed by dividing earnings (or loss) available to common shareholders by the weighted-average number of common shares outstanding. Diluted earnings (or loss) per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential shares of common stock had been issued and if the additional shares were dilutive. Common stock equivalents are excluded from the diluted earnings (or loss) per share computation if their effect is anti-dilutive. Common stock equivalents in amounts of 1,042,211 and 1,000,000 were excluded from the computation of diluted earnings per share for the nine months ended July 31, 2024, and 2023, respectively, because their effects would have been anti-dilutive.

Schedule of earnings per share

	July 31, 2024		July 31, 2023
Convertible notes	$	42,211	$	—
Convertible preferred stock		1,000,000		1,000,000
Total	$	1,042,211	$	1,000,000

Business Segments

The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments. The guidance in Accounting Standards Update (“ASU”) 2016-13 replaces the incurred loss impairment methodology under current GAAP. The new impairment model requires immediate recognition of estimated credit losses expected to occur for most financial assets and certain other instruments. It will apply to trade receivables, loans, and held-to-maturity debt securities. Entities will be required to estimate lifetime expected credit losses. This may result in earlier recognition of credit losses. In November 2019 the FASB issued ASU No. 2019-10, which delays this standard’s effective date for SEC smaller reporting companies to the fiscal years beginning on or after December 15, 2022. The Company determined that this update did not have a material impact on the financial statements upon adoption on November 1, 2023.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. Entities will be required to disclose additional information in specified categories in the reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The standard also requires greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold and eliminates certain existing disclosures. In addition to new disclosures associated with the rate reconciliation, the standard requires information pertaining to taxes paid (net of refunds received) to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The standard will be effective for annual periods in fiscal years beginning after December 15, 2024, and for interim periods for fiscal years beginning after December 15, 2025 with early adoption permitted. The Company is continuing to assess the potential impacts of the standard, and it does not expect this pronouncement to have a material effect on its financial statements, other than the required changes to the income tax disclosures

NOTE 2 – GOING CONCERN

These unaudited condensed consolidated financial statements have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company’s management has evaluated whether there is substantial doubt about the Company’s ability to continue as a going concern and has determined that substantial doubt existed as of the date of the end of the period covered by this report. This determination was based on the following factors: (i) the Company used cash of approximately $470 thousand in operations during the nine months ended July 31, 2024 and has a working capital of approximately $261 thousand at July 31, 2024; (ii) the Company’s available cash as of the date of this filing will not be sufficient to fund its anticipated level of operations for the next 12 months; (iii) the Company will require additional financing for the fiscal year ending October 31, 2024, to continue at its expected level of operations; and (iv) if the Company fails to obtain the needed capital, it will be forced to delay, scale back, or eliminate some or all of its development activities or perhaps cease operations. In the opinion of management, these factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern as of the date of the end of the period covered by this report and for one year from the issuance of these condensed consolidated financial statements.

Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, reduce the scope of, or eliminate one or more of the Company’s research and development activities or commercialization efforts or perhaps even cease the operation of its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.

NOTE 3 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Subsequent to the Company’s filing of its Annual Report on Form 10-K for the fiscal year ended October 31, 2023 and its Quarterly Report on Form 10-Q for the three and nine months ended July 31, 2023, with the Securities and Exchange Commission on September 22, 2023, the Company performed an evaluation of its accounting policies in relation to the fair value of its common stock. Management determined that the Original Forms 10-K and 10-Q do not give effect to certain expenses identified. Accordingly, the Company restates its consolidated financial statements in this Form 10-Q as outlined further below. Upon review of the Company’s previously filed Forms 10-K and 10-Q, the following errors were discovered and recorded:

Prepared the July 31, 2023, cash flow statement in accordance with GAAP to correct previous inconsistencies with the preparation of the report.

Reclassified $100,000 of consulting and development services expense to ‘Due to related party’

Adjusted stock-based compensation expense and related addition paid-in capital and reclassified it to an individual line within the operating expenses

	4.	Included additional expense already maintained in the Companies system within general and administrative expenses
	5.	Included developmental expenses within general and administrative expenses

The following table sets forth the effects of the adjustments on affected items within the Company’s previously reported condensed consolidated statement of operations for the three and nine months ended July 31, 2023:


	For the Three Months Ended										For the Nine Months Ended
	July 31,							July 31,			July 31,							July 31,
	2023			Adjustments				2023			2023			Adjustments				2023
	(As Filed)							(As Restated)			(As Filed)							(As Restated)
Revenues	$	228,518		$	—			$	228,518		$	682,290		$	—			$	682,290
Cost of sales		—			—				—			—			—				—
Gross profit (loss)		228,518			—				228,518			682,290			—				682,290

Operating expenses:
General and administrative expenses		379,295			2,457,265		2,4		2,836,560			831,237			3,022,676		2,4		3,853,913
Development expenses		2,185,420			(2,185,420	)	5		—			3,154,142			(3,154,142	)	5		—
Stock based compensation		—			448,430		3		448,430			—			1,959,107		3		1,959,107
Total operating expenses		2,564,715			720,275				3,284,990			3,985,379			1,827,641				5,813,020

Loss from operations		(2,336,197	)		(720,275	)			(3,056,472	)		(3,303,089	)		(1,827,641	)			(5,130,730	)

Other income (expense):
Other income (expense)		334,743			—				334,743			(750	)		—				(750	)
Total other income (expense)		334,743			—				334,743			(750	)		—				(750	)

Net loss before taxes		(2,001,454	)		(720,275	)			(2,721,729	)		(3,303,839	)		(1,827,641	)			(5,131,480	)
Income tax provision (benefit)		—			—				—			—			—				—
Net loss	$	(2,001,454	)	$	(720,275	)		$	(2,721,729	)	$	(3,303,839	)	$	(1,827,641	)		$	(5,131,480	)

Net loss per share, basic and diluted	$	(0.04	)	$				$	(0.02	)	$	(0.06	)	$				$	(0.10	)
Weighted average shares outstanding, basic and diluted		51,295,583							114,065,825			51,295,583							50,007,263

The following table sets forth the effects of the adjustments on affected items within the Company’s previously reported consolidated statements of cash flows for the nine months ended July 31, 2023:


	For the nine months ended July 31, 2023			Adjustments				For the nine months ended July 31, 2023
	(As Filed)							(As Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,303,839	)		(1,827,641	) 1		$	(5,131,480	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock		—			1,959,095		1		1,959,095
Amortization of debt discount related to derivatives		—			1,047,879		1		1,047,879
Change in fair value of derivative liability		—			(1,047,879	)	1		(1,047,879	)
Changes in operating assets and liabilities
Increase in accounts receivable		(680,658	)		—				(680,658	)
Increase in accounts payable and accrued liabilities		73,363			61,670		1		135,033
Net cash used in operating activities	$	(3,911,134	)		193,124			$	(3,718,010	)

CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments		(18,818,285	)		18,818,285		1		—
Net cash used in investing activities	$	(18,818,285	)		18,818,285			$	—

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		—			3,718,010		1		3,718,010
Additional paid-in capital		22,785,154			(22,785,154	)	1		—
Common stock		107,236			(107,236	)	1		—
Net cash provided by financing activities	$	22,892,390			(19,174,380	)		$	3,718,010

Net increase (decrease) in cash and cash equivalents		162,971			(162,971	) 1			—
Cash and cash equivalents, beginning of the period		(32,453	)		32,453				—
Cash and cash equivalents, end of the period	$	130,518			(130,518	) 1		$	—

Supplemental disclosures for cash flow information:
Cash paid during the period for interest	$	—						$	—

Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition	$	—		$	14,778,000	1		$	14,778,000
Reduction of common stock to be issued for acquisition	$	—		$	1,812,769	1		$	1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition	$	—		$	522,659			$	522,659
Issuance of common stock upon conversion of notes payable	$	—		$	3,781,478	1		$	3,781,478
Purchase of intangible assets related to the Cilandro acquisition	$	—		$	158,000	1		$	158,000
Issuance of common stock for intangible assets related to the Cilandro acquisition	$	—		$	110,000	1		$	110,000

NOTE 4 - REVENUES

Revenues

For the three months ended July 31, 2024, Arax Holdings Corp. reported revenue of $0, compared to $226,886 for the same period in 2023. For the nine months ended July 31, 2024, the Company reported revenue of $528,636, compared to $682,290 for the same period in 2023.

The decrease in revenue for the three months ended July 31, 2024 as compared to the same period in a prior year is primarily due to the timing of completion of the specific projects during the quarter.

The decrease in revenue for the nine months ended July 31, 2024 as compared to the same period in a prior year is primarily due to the delay in completions for the specific projects during the year.

●

Service Offerings: Include software subscriptions that require secure access, enabling user interactions via blockchain networks

●

Use Cases: The Company develops tailored solutions, known as Use Cases, which can incorporate both physical inventory and software components. These are customized for each client

●

Cost Sharing: In some instances, the Company co-invests in the initial setup infrastructure costs with government or enterprise partners

●

Revenue Model: Primarily, revenue is derived from subscription fees and transaction fees associated with blockchain interactions, rather than from the initial infrastructure investments.

Disaggregation of Revenue

The following tables provide a disaggregation of revenue by major product line and timing of revenue recognition for the periods presented:

	For the three months ended				For the nine months ended
Product Line	July 31, 2024		July 31, 2023		July 31, 2024		July 31, 2023
BaaP Software Modules	$	—	$	228,518	$	258,320	$	428,518
Consulting and Integration Services		—		—		160,000		150,000
Subscription Services		—		—		110,316		103,772
Total	$	—	$	228,518	$	528,636	$	682,290

NOTE 5 – ASSETS ACQUSITION

Core Business Holdings Acquisition

In December 2022, Arax Holdings Corp. completed the acquisition of Core Business Holdings for a total consideration of $18,000,000. This transaction is classified as an asset acquisition rather than a business combination in accordance with ASC Topic 805-50, due to the nature of the acquired assets being solely intellectual properties (IP) without substantive processes or outputs necessary to meet the definition of a business under ASC 805-10-55.

The intellectual properties, valued at $18,000,000, represent developed software on an emerging blockchain technology platform. These assets are recognized at cost, as there were no processes or outputs to suggest a valuation above the direct costs incurred. Consequently, no goodwill or additional value was recognized in this transaction.

This transaction was between related parties and, as required by ASC 850, all relevant details of the transaction have been fully disclosed. The acquisition was conducted at fair value, which coincides with the direct costs associated with the development of the acquired software IP. Such transactions were scrutinized to ensure they reflect terms that are consistent with market practices and did not result from motivations that would detract from the interests of the shareholders.

Impairment Review and Measurement: Consistent with IAS 36 on Impairment of Assets, and in compliance with GAAP accounting standards on impairment of assets, ARAX Holdings Corp. conducts periodic reviews of asset values to ensure they are not recorded at more than their recoverable amount. Consistent with these principles, an impairment loss was recognized for the recently acquired assets from the related party transaction involving Core Business Holdings.

The impairment was necessitated by the related party nature of the transaction, which requires a cautious approach to valuation until a formal, independent valuation is available. As of the reporting date, the impairment recognized amounted to $18,550,285, reflecting the difference between the asset’s carrying value at acquisition and its fair value, adjusted for this impairment.

The recoverable amount of the assets was determined based on the higher of the fair value less costs of disposal or the value in use at the time of impairment testing. This approach ensures that the assets are measured fairly and conservatively, reflecting their current economic worth to the company.

ARAX Holdings Corp. asserts that these financial statements accurately reflect the comprehensive details of the acquisition and subsequent impairment. This disclosure is intended to provide stakeholders with clear and reliable information regarding the financial implications and the nature of the transaction, maintaining transparency and adherence to regulatory requirements.

This format adheres to SEC and GAAP guidelines, ensuring that all necessary details concerning the impairment and the related party transaction are comprehensively and transparently reported.

Cilandro SA Acquisition

On May 3, 2023, the Company acquired 100% of Cilandro SA registered under Swiss law (“Cilandro”). The acquisition did not qualify as a business combination and, as a result, was accounted for as an asset acquisition as the fair value of the gross assets acquired was primarily related to a single asset. The Company issued 110,000 shares of the Company’s common stock to Cilandro, and a convertible promissory note with the principal of $58,000, and assumed approximately $100,000 in accrued liability for Cilandro, reflecting an aggregate purchase price of $268,000.


Consideration
Issuance of common stock	$	110,000
Issuance of convertible note		58,000
Liability assumed		100,000
Total consideration	$	268,000

Asset Acquired
Financial license	$	268,000

NOTE 6 - CAPITALIZED SOFTWARE DEVELOPMENT COSTS

Software development costs capitalized as of July 31, 2024 and October 31, 2023, were $6,405,952 and $5,033,332 respectively. Capitalized software includes acquired software and direct labor and related expenses for software developed for sale for BaaP (Blockchain-as-a-Platform) software solutions.

In accordance with the Generally Accepted Accounting Principles (GAAP), ARAX Holdings Corp. has adopted a systematic and rational methodology for the capitalization of certain software development costs, as outlined in the GAAP guidelines under Paragraph 985-20-25-2(a). This process involves three essential criteria related to detailed program design that must be met before the commencement of capitalization. The acquisition of Core Business Holdings (CBH) came after CBH had completed the Program Design, Research & Development, Product Design, and Testing phases for four pivotal software platforms. Illustrated from Industry Standards and reputable development repository for storage of code and activities, the dates of completion of the software platforms were:

● Core Token and Smart Contract Platform: 06/06/2021
● Ping Exchange: 01/22/2021
● Wall Money: 03/13/2021
● Core Pay: 05/14/2019

The valuation of this acquisition was primarily based on the actual expenditures incurred during these phases, bringing these software platforms to a stage where they were feasible and ready for production. Subsequent to this acquisition, these software platforms were used in Arax’s Blockchain as a Platform (BaaP) production to the point of being ready for consumer release.

According to Paragraph 985-20-25-2, CBH had to perform minimum activities as evidence that technological feasibility had been established:

Meeting the 4 criteria for establishing technological feasibility the designs had to be completed to have the platform operative to complete initial customer testing which was conducted immediately after deployments. The completion of User Specifications and Requirements was part of the criteria needed to satisfy the software’s feasibility point prior to acquisition.

ASC 985-20 focuses on the accounting for external-use software, emphasizing that all nsoftware development costs incurred before establishing the technological feasibility of the software product should be expensed. Once technological feasibility is established, without any remaining ‘high-risk’ development issues, development costs incurred thereafter (production costs) are to be capitalized to the extent they are recoverable by the software product’s net realizable value until the product is ready for general release. This directive applies not only to the development of new software products but also to enhancements of existing software products, where a ‘product enhancement’ refers to an improvement that significantly enhances the software product’s marketability or extends its useful life.

NOTE 7 – INTANGIBLE ASSETS

As of July 31, 2024 and October 31, 2023, respectively, the Company had $268,000 of recognized indefinite lived intangible assets, which consist of customer contract assets from acquisitions and costs capitalized. These assets are not amortized and are evaluated routinely for potential impairment. If a determination is made that the intangible asset is impaired after performing the initial qualitative assessment, the asset’s fair value will be calculated and compared with the carrying value to determine whether an impairment loss should be recognized. The Company did not recognize any intangible asset impairment charges during the three and nine months ended July 31, 2024 or 2023.

NOTE 8 - DEBT

Convertible Notes Issued in 2024

On various dates during the three and nine months ended July 31, 2024, the Company entered into a series of convertible promissory notes totalling $267,000 and $362,000, respectively, in proceeds received. These notes each bear interest on the unpaid principal balance at a rate equal to ten percent (10%) per annum, accruing from the date of issuance until the note becomes due and payable at maturity. All principal and interest accrued shall be due two years from the initial borrowing date.

After two days from the effective date of each respective note, each noteholder shall have the right at any time to convert the outstanding principal in whole or in part into shares of common stock. For the first 60 days following the execution of the agreement, the conversion price shall be equal to a range from $0.55 to $0.80 for each common share, identified in each individual note agreement. After 60 days following the execution of the agreement, the conversion price will be 80% of the average of the lowest three closing prices of the Company’s common stock during the 10 consecutive trading days prior to the date the Holder elects to convert all or part of the note.

During the nine months ended July 31, 2024, the holders of several notes exercised the conversion option for the full balance of each respective note. As a result, during the three months ended July 31, 2024, the Company issued a grand total of 390,342 shares of common stock at conversion rates between $0.55 and $0.80 for total consideration of approximately $256,743. During the nine months ended July 31, 2024, the Company issued a grand total of 555,051 shares of common stock at conversion rates between $0.55 and $0.80 for total consideration of approximately $352,173.

As of July 31, 2024, the outstanding balance on the remaining notes amounts to $11,000.

Short-Term Borrowings

On May 1, 2024, the Company received a total of $44,000 from a lender as a short-term borrowing with no defined contract terms. On May 10, 2024, the Company agreed to settle the outstanding short-term borrowing with 110,000 shares of common stock issued. The fair value of the common stock issued was determined using the stock price as of the date of the settlement at $1.34 per share or $147,400 in total. As a result of this transaction the Company recorded a loss on extinguishment of short-term borrowing for the total amount of $103,400 being included in other expense within accompanying statement of operations for the three and note months periods ended July 31, 2024.

NOTE 9 – EQUITY

Preferred Stock

The Company has authorized 10,000,000 shares of $0.001 par value, preferred stock. As of July 31, 2024 and October 31, 2023 there were 10,000,000 shares of preferred stock issued and outstanding.

On March 31, 2021, the Company issued 10,000,000 shares of Series A Preferred Stock with a par value of $0.001. The Series A shares are convertible into common stock on a 10 for 1 basis and were issued in return for a reduction of $16,166 of related party debt. Due to the thinly traded nature of the Company’s stock and its status as a “shell”, the Company used the par value of the common stock, which was determined to be $100,000, to value this issuance and recorded $16,166 for repayment of the loan and $83,834 as share-based compensation in the Company’s Statements of Operations.

Common Stock

The Company has authorized 950,000,000 shares of $0.0001 par value, common stock. As of July 31, 2024, and October 31, 2023 there were 128,253,557 and 126,160,534 shares of common stock issued and outstanding.

2024 Activity

Issuance of common stock in exchange for services performed

During the nine months ended July 31, 2024 the Company issued 611,747 shares of common stock to a consultant for a total of $721,800 recognized as stock compensation.

Reduction of common stock to be issued in connection with acquisition

During the nine months ended July 31, 2024 the Company issued 816,225 shares, valued at $540,000, in connection with the acquisition of Core Business Holdings (See Note 5). These shares had previously been included under Common stock to be issued as of April 30, 2024.

Issuance of common stock in connection with debt

During the nine months ended July 31, 2024 the Company issued 164,709 shares of common stock to three noteholders who elected to convert $95,000 in notes payable into equity of the Company (see Note 8).

Issuance of common stock upon conversion of convertible promissory notes

During the nine months ended July 31, 2024 the Company issued 500,342 shares of common stock in connection with the conversion of $404,143 of convertible notes payable (See Note 8).

Issuance of common stock upon settlement of short-term borrowing

On May 10, 2024, the Company agreed to settle the outstanding short-term borrowing with 110,000 shares of common stock issued. The fair value of the common stock issued was determined using the stock price as of the date of the settlement at $1.34 per share or $147,400 in total (See Note 8).

2023 Activity

Issuance of common stock in connection with acquisition

During the nine months ended July 31, 2023 the Company issued 90,215,096 shares of common stock, and agreed to issue an additional $3,222,000 worth of common stock to five individuals in connection with the acquisition of Core Business Holdings. The common stock issued, and agreed to be issued in the future, in connection with the acquisition of Core Business Holdings (See Note 5), was valued at $18,000,000.

During the nine months ended July 31, 2023 the Company issued 2,619,875 shares of common stock in connection with the conversion of $550,285 of convertible notes payable.

During the nine months ended July 31, 2023 the Company issued 2,847,381 shares, valued at $1,812,769, in connection with the acquisition of Core Business Holdings (See Note 5). These shares had previously been included under Common stock to be issued as of April 30, 2023.

Issuance of common stock upon conversion of convertible promissory notes

During the nine months ended July 31, 2023 the Company issued 9,514,525 shares of common stock in connection with the conversion of $3,930,768 of convertible notes payable.

Issuance of common stock in exchange for services performed

During the nine months ended July 31, 2023 the Company issued 2,038,744 shares of common stock to a consultant for a total of $1,959,107 recognized as stock compensation.

NOTE 10 – COMMITMENTS AND CONTINGENCIES

In the ordinary course of business, the Company enters into various agreements containing standard indemnification provisions. The Company’s indemnification obligations under such provisions are typically in effect from the date of execution of the applicable agreement through the end of the applicable statute of limitations. The aggregate maximum potential future liability of the Company under such indemnification provisions is uncertain. As of July 31, 2024 and October 31, 2023, no amounts have been accrued related to such indemnification provisions.

NOTE 11 – ADVANCES FROM RELATED PARTY

An entity controlled by the Company’s Chairman has advanced an aggregate of $57,756 to the Company as of July 31, 2024 and October 31, 2023. These funds were used to pay corporate expenses of the Company, and the payments were made directly to the vendors by this entity.

In determining the transaction price allocated to performance obligations, the Company considers the terms of the contracts and its customary business practices. Significant judgment is required in determining whether performance obligations are satisfied over time or at a point in time, and the measurement of progress toward complete satisfaction of performance obligations.

NOTE 12 – SUBSEQUENT EVENTS

In accordance with FASB ASC 855-10, Subsequent Events, the Company has analysed its operations subsequent to July 31, 2024, to the date these financial statements were issued.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

Arax Holdings Corp. (the “Company”, “we”, “our” or “us”) was incorporated under the laws of the State of Nevada on February 23, 2012. Our financial statements accompanying this Report have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. We have a minimal operating history and minimal revenues or earnings from operations.

Plan of Operation

The Company has operations from a continuing business providing software and logistics services to a company in South Africa. The Company intends to develop this relationship while expanding in other areas of the world. The Company has acquired financial licenses in Switzerland under the entity Cilandro and is currently working to provide Central Business Digital Currencies for various entities worldwide. The Company will continue to develop software solutions that work exclusively on the Core Blockchain to maximize its potential for revenue generation in this new technology released in May of 2022. The Company has entered into consulting and design agreements from continuing business and is in the process of evaluating additional acquisitions of software technologies.

Management intends to explore and identify business opportunities within the U.S., including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. Our Chief Executive Officer has experience in business consulting, although no assurances can be given that he can identify and implement a viable business strategy or that any such strategy will result in profits. Our ability to effectively identify, develop and implement a viable plan for our business may be hindered by risks and uncertainties which are beyond our control, including without limitation, the continued negative effects of the coronavirus pandemic on the U.S. and global economies.

Given our limited capital resources, we may consider a business combination with an entity that has recently commenced operations, is a developing company or is otherwise in need of additional funds for the development of new products or services or expansion into new markets, or is an established business experiencing financial or operating difficulties and requires additional capital. Alternatively, a business combination may involve the acquisition of, or merger with, an entity that desires access to the U.S. capital markets.

As of the date of this Report, our management has continued to complete the acquisition of certain technologies and software businesses including the Core Business Holdings Group and Cilandro. These businesses, technology, and any other target business that are selected may be financially unstable or in the early stages of development. In such an event, we expect to be subject to numerous risks inherent in the business and operations of a financially unstable or early-stage entity. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk or in which our management has limited experience, and, although our management will endeavour to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks.

Our management anticipates that we will likely only be able to effect one business combination due to our limited capital. This lack of diversification will likely pose a substantial risk in investing in the Company for the indefinite future because it will not permit us to offset potential losses from one venture or operating territory against gains from another. The risks we face will likely be heightened to the extent we acquire a business operating in a single industry or geographical region.

We anticipate that the selection of a business combination will be a complex and risk-prone process. Because of general economic conditions, including unfavorable conditions caused by the coronavirus pandemic, rapid technological advances being made in some industries and shortages of available capital, management believes that there are a number of firms seeking business opportunities at this time at discounted rates with which we will compete. We expect that any potentially available business combinations may appear in a variety of different industries or regions and at various stages of development, all of which will likely render the task of comparative investigation and analysis of such business opportunities extremely difficult and complicated. Once we have developed and begun to implement our business plan, management intends to fund our working capital requirements through a combination of our existing funds and future issuances of debt or equity securities. Our working capital requirements are expected to increase in line with the implementation of a business plan and commencement of operations.

We anticipate that we will incur operating losses in the next 12 months, principally costs related to our being obligated to file reports with the SEC. Our prospects must be considered in light of the risks, expenses, and difficulties frequently encountered by companies in their early stage of development. Such risks for us include but are not limited to, an evolving and unpredictable business model, recognition of revenue sources, and the management of growth. To address these risks, we must, among other things, develop, implement, and successfully execute our business and marketing strategy, respond to competitive developments, and attract, retain, and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so could have a material adverse effect on our business prospects, financial condition, and results of operations.

Limited Operating History; Need for Additional Capital

We cannot guarantee we will be successful in our business operations. We have not generated any revenue since inception. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources.

If we are unable to meet our needs for cash from either our operations or possible alternative sources, then we may be unable to develop our operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Going Concern

Our July 31, 2024, financial statements indicate that our capital resources as of the report date were not sufficient to sustain operations or complete our planned activities for the upcoming year. This assessment is made in accordance with the going concern disclosure requirements set forth by Generally Accepted Accounting Principles (GAAP) and Accounting Standards Codification (ASC) rules.

Critical Accounting Principles

The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates. We have not identified any critical accounting policies.

Result of Operations

Three Months Ended July 31, 2024 Compared to the Three Months Ended July 31, 2023

Revenue

We had $0 and $228,518 in revenue during the three months ending July 31, 2024 and July 31, 2023 respectively. The decrease of $228,518 or 100% was due to the timing of completion of the specific projects during the quarter.

Operating Expenses

Our general and administrative expenses consist of professional fees and other costs incurred in connection with maintaining the Company’s filings with the Securities and Exchange Commission and the payment of vendors associated with the issuance and trading of the Company’s securities, such as transfer agent fees.

We had total operating expenses of $329 thousand for the three-month period ended July 31, 2024, compared to $2.8 million for the corresponding three-month period in 2023, a decrease of $2.5 million or 88%. This decrease was due to decreases in legal and professional fees of approximately $2.6 million, partially offset by an increase in consulting and development services of approximately $106 thousand.

Other Income (Expense)

Other income (expense) for the three-month period ended July 31, 2024, was expense of $104 thousand compared to income of $334 thousand in the corresponding 2023 period. During the three month period ended July 31, 2024, other expense was primarily comprised of a $103 thousand loss on short-term borrowing settlements while the other income for the corresponding period in 2023 was primarily comprised of $335 thousand of amortization.

Net Loss

For the three-months ended July 31, 2024, we had a net loss from continuing operations of $433 thousand compared to a net loss of $2.3 million during the corresponding three-month period in 2023.

Nine Months Ended July 31, 2024 Compared to the Nine Months Ended July 31, 2023

Revenue

We had $528,636 and $682,290 in revenue during the nine months ending July 31, 2024 and July 31, 2023 respectively. The decrease of $153,654 or 23% resulted primarily due to the delay in completions for the specific projects during the year.

Operating Expenses

We had total operating expenses of $1.3 million for the nine-month period ended July 31, 2024, compared to $5.8 million for the corresponding nine-month period in 2023, a decrease of $4.5 million or 77%. This decrease was due to decreases in general and administrative of $3.2 million and stock-based compensation expense of $1.2 million, respectively. The decrease in general and administrative expenses for the comparative periods can be attributed to a decrease in consulting and development services of $3.3 million, partially offset by an increase in accounting fees of approximately $61 thousand. The decrease in the current period consulting and development services is due to the timing of certain projects performed in the prior year.

Other Income (Expense)

Other income (expense) for the nine-month period ended July 31, 2024, was expense of $104 thousand compared to expense of $750 in the corresponding 2023 period. The increase in expense of approximately $103 thousand is attributable to

Net Loss

For the nine-months ended July 31, 2024, we had a net loss from continuing operations of $906 thousand compared to a net loss of $5.1 million during the corresponding nine-month period in 2023.

Liquidity and Capital Resources

For the nine months ended July 31, 2024, net cash used in operating activities was $470 thousand, compared to net cash used in operating activities of $3.7 million for the corresponding nine-month period in 2023. For the nine months ended July 31, 2024, net loss was $906 thousand. Net loss includes depreciation and amortization expense of $453, equity-based compensation expense of $722 thousand, loss on debt settlement of $103 thousand, noncash interest expense of $377, and changes in operating assets and liabilities of $390 thousand.

For the nine months ended July 31, 2023, net loss was $5.1 million. Net loss includes equity-based compensation expense of $2.0 million, amortization of debt discount related to derivatives of $1.0 million, change in fair value of derivative liability of $1.0 million, and changes in operating assets and liabilities of $546 thousand.

For the nine months ended July 31, 2024 and 2023, net cash used by investing activities was $1,372,620 and $0, respectively. The Company capitalized $1.4 million of software and development costs (see Note 6).

For the nine months ended July 31, 2024 and 2023, net cash provided by financing activities was $406 thousand and $3.7 million, respectively. The Company received $362,000 from the issuance of notes payable in 2024 and $1,539,000 from the issuance of notes payable in 2023. The Company received $44,000 in proceeds from short-term borrowings during the nine months ended July 31, 2024.

Based on our current operations, we do not have sufficient working capital to fund our operations over the next 12 months. Because of the uncertainties, we cannot be certain as to how much capital we need to raise or the type of securities we will be required to issue. In connection with any acquisition, or reverse merger, we may be required to issue a controlling block of our securities to the target’s shareholders which will be very dilutive.

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our Common Stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

We currently are dependent on the issuance of convertible debt financing and an entity controlled by the Company’s Chairman for funds used to pay corporate expenses of the Company, and the payments made by the controlling entity were made directly to the vendors by this entity.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the sensitivity of income or loss to changes in interest rates, foreign exchanges, commodity prices, equity prices, and other market-driven rates or prices. We are not presently engaged in any substantive commercial business. Accordingly, the risks associated with foreign exchange rates, commodity prices, and equity prices are not significant. Our debt obligations contain interest rates that are fixed, and we do not enter into derivatives or other financial instruments for trading or speculative purposes.

Item 4. Controls and Procedures

(a) Disclosure Controls and Procedures

As of July 31, 2024 being the end of the period covered by this Report, we carried out an evaluation required by Rule 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” and “internal control over financial reporting” as of the end of the period covered by this Quarterly Report.

We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act that are designed to ensure that information required to be disclosed in our reports filed or submitted to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and that information is accumulated and communicated to management, including the principal executive and financial officer as appropriate, to allow timely decisions regarding required disclosures. Our principal executive officer and principal financial officer evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by this quarterly report (the “Evaluation Date”), pursuant to Rule 13a- 15(b) under the Exchange Act. Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure, due to material weaknesses in our control environment and financial reporting process.

Our management, including our principal executive officer and principal financial officer, does not expect that our Disclosure Controls and internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management or board override of the control.

The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

(b) Management’s Quarterly Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). In evaluating the effectiveness of our internal control over financial reporting, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (b) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of the Company are being made only in accordance with authorizations of the our management and directors; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Based on our evaluation under the framework described above, as of July 31, 2024, our management concluded that we had “material weaknesses” (as such term is defined below) in our control environment and financial reporting process consisting of the following as of the Evaluation Date:

1) The Company does not have sufficient segregation of duties within accounting functions due to its limited staff and limited resources;

2) The Company does not have an independent board of directors or an audit committee;

3) The Company does not have written documentation of our internal control policies and procedures; and

4) All of the Company’s financial reporting is conducted by a financial consultant.

A “material weakness” is defined under SEC rules as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

We plan to rectify these weaknesses by implementing an independent board of directors, establishing written policies and procedures for our internal control of financial reporting, and hiring additional accounting personnel at such time as we complete a reverse merger or similar business acquisition.

(c) Change in Internal Control over Financial Reporting

There were no significant changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our second fiscal quarter that could materially affect, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

None.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1a. Risk Factors

We are a smaller reporting company and are not required to provide the information under this item pursuant to Regulation S-K.

Item 2. Unregistered Sales of Equity Securities And Use Of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

Item 6. Exhibits

31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Arax Holdings Corp
	(Registrant)

Dated: September 23, 2024	By:	/s/ Michael Loubser
		Michael Loubser, Chief Executive Officer (Principal Executive Officer)
	By:	/s/ Christopher Strachan
		Christopher Strachan, Chief Financial Officer (Principal Financial Officer)

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT

RULE 13a-14(a)
(as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002)

I, Michael Loubser, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Arax Holdings Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: September 23, 2024

By:

/s/ Michael Loubser

Michael Loubser, Chief Executive Officer

(Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE

13a-14(a)
(as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002)

I, Christopher Strachan, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Arax Holdings Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: September 23, 2024

By:

/s/ Christopher Strachan

Christopher Strachan, Chief Financial Officer

(Principal Financial and Accounting Officer)

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the Quarterly Report of Arax Holdings Corp. (the “Company”) on Form 10-Q for the quarter ended July 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), Michael Loubser, Chief Executive Officer of the Company, does hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to his knowledge:

	(1)	the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

September 23, 2024	/s/ Michael Loubser
	Name:	Michael Loubser
	Title:	Chief Executive Officer (Principal Executive Officer)

[A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.]

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the Quarterly Report of Arax Holdings Corp. (the “Company”) on Form 10-Q for the quarter ended July 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), Christopher Strachan, Chief Financial Officer and Principal Financial and Accounting Officer of the Company, does hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to his knowledge:

	(1)	the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

September 23, 2024	/s/ Christopher Strachan
	Christopher Strachan, Chief Financial Officer (Principal Financial and Accounting Officer)

Cover - shares	9 Months Ended
Cover - shares	Jul. 31, 2024	Sep. 20, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jul. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--10-31
Entity File Number	333-185928
Entity Registrant Name	ARAX HOLDINGS CORP.
Entity Central Index Key	0001566243
Entity Tax Identification Number	99-0376721
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	820 E Park Ave
Entity Address, Address Line Two	Blvd D200
Entity Address, City or Town	Tallahassee
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32301
City Area Code	850
Local Phone Number	254-1161
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		128,376,886

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)	Jul. 31, 2024	Oct. 31, 2023
ASSETS
Cash	$ 12,169	$ 1,448,769
Accounts receivable	755,587	226,951
Total current assets	767,756	1,675,720
Property and equipment, net of accumulated depreciation of $532 and $79, respectively	1,057	1,510
Capitalized software development costs	6,405,952	5,033,332
Other assets	169,373	169,373
Intangible assets, net	268,000	268,000
Total assets	7,612,138	7,147,935
LIABILITIES & STOCKHOLDERS’ DEFICIT
Accounts payable	137,223	100,000
Accrued expenses	200,910	100,378
Due to related party	157,756	157,756
Notes payable	11,000
Total current liabilities	506,889	358,134
Total liabilities	506,889	358,134
Stockholders’ equity:
Preferred Stock Series A, par value $0.001, 10,000,000 shares authorized, 10,000,000 shares issued and outstanding as of July 31, 2024 and October 31, 2023, respectively	10,000	10,000
Common stock, Par Value $0.0001, 950,000,000 shares authorized, 128,253,557 and 126,160,534 issued and outstanding as of July 31, 2024 and October 31, 2023	12,825	12,616
Common stock to be issued	900,000	1,440,000
Additional paid in capital	29,682,169	27,920,998
Accumulated deficit	(23,499,745)	(22,593,813)
Total stockholders’ equity	7,105,249	6,789,801
Total liabilities and stockholders’ equity	$ 7,612,138	$ 7,147,935

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)	Jul. 31, 2024	Oct. 31, 2023
Property and equipment, net of accumulated depreciation	$ 532	$ 79
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	950,000,000	950,000,000
Common stock, shares, issued	128,253,557	126,160,534
Common stock, shares, outstanding	128,253,557	126,160,534
Series A Preferred Stock [Member]
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	10,000,000	10,000,000
Preferred stock, shares outstanding	10,000,000	10,000,000

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Income Statement [Abstract]
Revenue		$ 228,518	$ 528,636	$ 682,290
Cost of revenue
Gross Profit (Loss)		228,518	528,636	682,290
Operating expenses:
General and administrative expenses	329,765	2,836,560	608,904	3,853,913
Stock based compensation			721,861	1,959,107
Total Operating Expenses	329,765	2,836,560	1,330,765	5,813,020
LOSS FROM OPERATIONS	(329,765)	(2,608,042)	(802,129)	(5,130,730)
OTHER INCOME (EXPENSE):
Loss on short-term borrowing settlement	(103,400)		(103,400)
Other Income (Expense)	(101)	334,743	(403)	(750)
Total Other Income (Expense)	(103,501)	334,743	(103,803)	(750)
Net loss before taxes	(433,266)	(2,273,299)	(905,932)	(5,131,480)
Income tax provision (benefit)
Net loss	$ (433,266)	$ (2,273,299)	$ (905,932)	$ (5,131,480)
Net loss per share, basic and diluted	$ (0.00)	$ (0.02)	$ (0.01)	$ (0.10)
Weighted average shares outstanding, basic and diluted	128,066,699	114,065,825	127,256,650	50,007,263

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2022	$ 10,000	$ 1,034		$ 684,046	$ (879,006)	$ (183,926)
Beginning balance (in shares) at Oct. 31, 2022	10,000,000	10,335,294
Net Loss					(1,066,865)	(1,066,865)
Balance as of July 31, 2023 (restated) at Jan. 31, 2023	$ 10,000	$ 1,034		684,046	(1,945,871)	(1,250,791)
Ending balance (in shares) at Jan. 31, 2023	10,000,000	10,335,294
Beginning balance, value at Oct. 31, 2022	$ 10,000	$ 1,034		684,046	(879,006)	(183,926)
Beginning balance (in shares) at Oct. 31, 2022	10,000,000	10,335,294
Common stock issued for services		$ 1,959,107
Common stock issued for services (in shares)		2,038,744
Issuance of common stock for acquisition (in shares)		90,215,096
Balance as of July 31, 2023 (restated) at Jul. 31, 2023	$ 10,000	$ 11,757	1,470,000	23,643,483	(6,010,486)	19,124,754
Ending balance (in shares) at Jul. 31, 2023	10,000,000	117,570,915
Beginning balance, value at Jan. 31, 2023	$ 10,000	$ 1,034		684,046	(1,945,871)	(1,250,791)
Beginning balance (in shares) at Jan. 31, 2023	10,000,000	10,335,294
Common stock issued for services		$ 204	3,143	1,955,761		1,959,108
Common stock issued for services (in shares)		2,038,744
Net Loss					(1,791,316)	(1,791,316)
Common stock issued for acquisition		$ 9,022	3,222,000	14,768,978		18,000,000
Issuance of common stock for acquisition (in shares)		90,215,096
Issuance of common stock upon conversion of convertible promissory notes		$ 425		1,100,041		1,100,466
Issuance of common stock upon conversion of convertible promissory notes (in shares)		4,250,173
Issuance of common stock in the conversion of convertible notes related to the acquisition		$ 262	27,626	522,397		550,285
Balance as of July 31, 2023 (restated) at Apr. 30, 2023	$ 10,000	$ 10,946	3,252,769	19,031,223	(3,737,187)	18,567,751
Ending balance (in shares) at Apr. 30, 2023	10,000,000	109,459,182
Beginning balance, value at Jan. 31, 2023	$ 10,000	$ 1,034		684,046	(1,945,871)	(1,250,791)
Beginning balance (in shares) at Jan. 31, 2023	10,000,000	10,335,294
Issuance of common stock in the conversion of convertible notes related to the acquisition (in shares)		2,619,875
Balance as of July 31, 2023 (restated) at Apr. 30, 2024	$ 10,000	$ 12,775	900,000	29,278,076	(23,066,479)	7,134,372
Ending balance (in shares) at Apr. 30, 2024	10,000,000	127,753,215
Beginning balance, value at Apr. 30, 2023	$ 10,000	$ 10,946	3,252,769	19,031,223	(3,737,187)	18,567,751
Beginning balance (in shares) at Apr. 30, 2023	10,000,000	109,459,182
Net Loss					(2,273,299)	(2,273,299)
Common stock issued for acquisition		285	(1,812,769)	1,812,484
Issuance of common stock upon conversion of convertible promissory notes		526	30,000	2,799,776		2,830,302
Balance as of July 31, 2023 (restated) at Jul. 31, 2023	$ 10,000	$ 11,757	1,470,000	23,643,483	(6,010,486)	19,124,754
Ending balance (in shares) at Jul. 31, 2023	10,000,000	117,570,915
Beginning balance, value at Oct. 31, 2023	$ 10,000	$ 12,616	1,440,000	27,920,998	(22,593,813)	6,789,801
Beginning balance (in shares) at Oct. 31, 2023	10,000,000	126,160,534
Common stock issued for services		$ 62		721,800		721,862
Common stock issued for services (in shares)		611,747
Reduction of common stock to be issued for acquisition		$ 54	(360,000)	359,946
Reduction of common stock to be issued for acquisition (in shares)		544,150
Net Loss					(685,994)	(685,994)
Balance as of July 31, 2023 (restated) at Jan. 31, 2024	$ 10,000	$ 12,732	1,080,000	29,002,744	(23,279,807)	6,825,669
Ending balance (in shares) at Jan. 31, 2024	10,000,000	127,316,431
Beginning balance, value at Oct. 31, 2023	$ 10,000	$ 12,616	1,440,000	27,920,998	(22,593,813)	6,789,801
Beginning balance (in shares) at Oct. 31, 2023	10,000,000	126,160,534
Common stock issued for services		$ 721,800
Common stock issued for services (in shares)		611,747
Common stock issued for acquisition		$ 540,000
Issuance of common stock for acquisition (in shares)		816,225
Balance as of July 31, 2023 (restated) at Jul. 31, 2024	$ 10,000	$ 12,825	900,000	29,682,169	(23,499,745)	7,105,249
Ending balance (in shares) at Jul. 31, 2024	10,000,000	128,253,557
Beginning balance, value at Jan. 31, 2024	$ 10,000	$ 12,732	1,080,000	29,002,744	(23,279,807)	6,825,669
Beginning balance (in shares) at Jan. 31, 2024	10,000,000	127,316,431
Reduction of common stock to be issued for acquisition		$ 27	(180,000)	179,973
Reduction of common stock to be issued for acquisition (in shares)		272,075
Net Loss					213,328	213,328
Issuance of common stock upon conversion of convertible notes		$ 16		95,359		95,376
Issuance of common stock upon conversion of convertible notes (in shares)		164,709
Balance as of July 31, 2023 (restated) at Apr. 30, 2024	$ 10,000	$ 12,775	900,000	29,278,076	(23,066,479)	7,134,372
Ending balance (in shares) at Apr. 30, 2024	10,000,000	127,753,215
Net Loss					(433,266)	(433,266)
Issuance of common stock upon conversion of convertible notes		$ 39		256,704		256,743
Issuance of common stock upon conversion of convertible notes (in shares)		390,342
Issuance of common stock upon settlement of short-term borrowings		$ 11		147,389		147,400
Issuance of common stock upon settlement of short-term borrowings (in shares)		110,000
Issuance of common stock for acquisition (in shares)		2,847,381
Issuance of common stock upon conversion of convertible promissory notes (in shares)		5,264,352
Balance as of July 31, 2023 (restated) at Jul. 31, 2024	$ 10,000	$ 12,825	$ 900,000	$ 29,682,169	$ (23,499,745)	$ 7,105,249
Ending balance (in shares) at Jul. 31, 2024	10,000,000	128,253,557

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (905,932)	$ (5,131,480)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of short-term borrowings	103,400
Depreciation and amortization expense	453
Noncash interest expense	377
Amortization of debt discount related to derivatives		1,047,879
Stock based compensation expense	721,862	1,959,095
Change in fair value of derivative liability		(1,047,879)
Changes in operating assets and liabilities
Increase in accounts receivable	(528,636)	(680,658)
Increase in accounts payable and accrued liabilities	138,496	135,033
Net cash used in operating activities	(469,980)	(3,718,010)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalized software and development costs	(1,372,620)
Net cash used in investing activities	(1,372,620)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	362,000	3,718,010
Proceeds from short-term borrowings	44,000
Net cash provided by financing activities	406,000	3,718,010
Net decrease in cash and cash equivalents	(1,436,600)
Cash and cash equivalents, beginning of the period	1,448,769
Cash and cash equivalents, end of the period	12,169
Supplemental disclosures for cash flow information:
Cash paid during the period for interest
Supplemental disclosure of Noncash financing activities:
Issuance of common stock for acquisition of Core Business Holdings		14,778,000
Reduction of common stock to be issued for acquisition of Core Business Holdings	540,000	1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition of Core Business Holdings		522,659
Issuance of common stock upon conversion of convertible notes	352,118	3,781,478
Issuance of common stock upon settlement of debt	147,400
Purchase of intangible assets related to the Cilandro acquisition		268,000
Issuance of common stock for intangible assets related to the Cilandro acquisition		$ 110,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Jul. 31, 2024

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

General

Arax Holdings Corp. (“the Company”) is a Nevada corporation incorporated on February 23, 2012.

The Company currently has operations from a growing business in the software development and integration marketplace.

Principles of Consolidation and Basis of Presentation

Use of Estimates

Cash

Revenue Recognition

●

Service Offerings: Include software subscriptions that require secure access, enabling user interactions via blockchain networks

●

Use Cases: The Company develops tailored solutions, known as Use Cases, which can incorporate both physical inventory and software components. These are customized for each client

●

Cost Sharing: In some instances, the Company co-invests in the initial setup infrastructure costs with government or enterprise partners

●

Revenue Model: Primarily, revenue is derived from subscription fees and transaction fees associated with blockchain interactions, rather than from the initial infrastructure investments

Contract Assets

The Company does not have any contract assets. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.

Cost of Revenues

Cost of revenues consists of employee costs, third party staffing costs and other fees, outsourced recruiter fees, and commissions. There have been no costs of revenue for the periods presented.

Accounts Receivable

Property and Equipment

Concentration of Credit Risk and Significant Customers and Vendors

As of July 31, 2024, and October 31, 2023 one customer accounted for all of the accounts receivable balance.

Research and Development

Advertising and Marketing Costs

The Company expenses all advertising and marketing costs as incurred. Advertising and marketing costs were not material for the three and nine months ended July 31, 2024 and 2023, respectively.

Fair Value of Financial Instruments and Fair Value Measurements

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.


Ending balance, October 31, 2022	$	—
Initial recognition of derivative liability:		1,047,879
Re-measurement adjustments:
Change in fair value of derivative liability		(1,047,879	)
Ending balance, July 31, 2023	$	—

The fair value of the derivative liability was estimated using binomial option-pricing model with the following assumptions:

	July 31, 2023
Stock Price on Valuation Date	$	0.70
Risk-Free Rate		5.53	%
Volatility		307.56	%
Term		2.5 yrs
Conversion price	$	0.2

Business Combinations

Intangible Assets

Long-lived Assets

Software Development Costs

Related Party Transactions

The Company considers all officers, directors, senior management personnel, and senior level consultants to be related parties to the Company.

Income Taxes

Stock-Based Compensation

Derivative Liabilities

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.

ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.

Leases

Loss per Share

Schedule of earnings per share

	July 31, 2024		July 31, 2023
Convertible notes	$	42,211	$	—
Convertible preferred stock		1,000,000		1,000,000
Total	$	1,042,211	$	1,000,000

Business Segments

Recently Issued Accounting Pronouncements

GOING CONCERN

9 Months Ended

Jul. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

NOTE 2 – GOING CONCERN

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

9 Months Ended

Jul. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 3 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Prepared the July 31, 2023, cash flow statement in accordance with GAAP to correct previous inconsistencies with the preparation of the report.

Reclassified $100,000 of consulting and development services expense to ‘Due to related party’

Adjusted stock-based compensation expense and related addition paid-in capital and reclassified it to an individual line within the operating expenses

	4.	Included additional expense already maintained in the Companies system within general and administrative expenses
	5.	Included developmental expenses within general and administrative expenses


	For the Three Months Ended										For the Nine Months Ended
	July 31,							July 31,			July 31,							July 31,
	2023			Adjustments				2023			2023			Adjustments				2023
	(As Filed)							(As Restated)			(As Filed)							(As Restated)
Revenues	$	228,518		$	—			$	228,518		$	682,290		$	—			$	682,290
Cost of sales		—			—				—			—			—				—
Gross profit (loss)		228,518			—				228,518			682,290			—				682,290

Operating expenses:
General and administrative expenses		379,295			2,457,265		2,4		2,836,560			831,237			3,022,676		2,4		3,853,913
Development expenses		2,185,420			(2,185,420	)	5		—			3,154,142			(3,154,142	)	5		—
Stock based compensation		—			448,430		3		448,430			—			1,959,107		3		1,959,107
Total operating expenses		2,564,715			720,275				3,284,990			3,985,379			1,827,641				5,813,020

Loss from operations		(2,336,197	)		(720,275	)			(3,056,472	)		(3,303,089	)		(1,827,641	)			(5,130,730	)

Other income (expense):
Other income (expense)		334,743			—				334,743			(750	)		—				(750	)
Total other income (expense)		334,743			—				334,743			(750	)		—				(750	)

Net loss before taxes		(2,001,454	)		(720,275	)			(2,721,729	)		(3,303,839	)		(1,827,641	)			(5,131,480	)
Income tax provision (benefit)		—			—				—			—			—				—
Net loss	$	(2,001,454	)	$	(720,275	)		$	(2,721,729	)	$	(3,303,839	)	$	(1,827,641	)		$	(5,131,480	)

Net loss per share, basic and diluted	$	(0.04	)	$				$	(0.02	)	$	(0.06	)	$				$	(0.10	)
Weighted average shares outstanding, basic and diluted		51,295,583							114,065,825			51,295,583							50,007,263


	For the nine months ended July 31, 2023			Adjustments				For the nine months ended July 31, 2023
	(As Filed)							(As Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,303,839	)		(1,827,641	) 1		$	(5,131,480	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock		—			1,959,095		1		1,959,095
Amortization of debt discount related to derivatives		—			1,047,879		1		1,047,879
Change in fair value of derivative liability		—			(1,047,879	)	1		(1,047,879	)
Changes in operating assets and liabilities
Increase in accounts receivable		(680,658	)		—				(680,658	)
Increase in accounts payable and accrued liabilities		73,363			61,670		1		135,033
Net cash used in operating activities	$	(3,911,134	)		193,124			$	(3,718,010	)

CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments		(18,818,285	)		18,818,285		1		—
Net cash used in investing activities	$	(18,818,285	)		18,818,285			$	—

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		—			3,718,010		1		3,718,010
Additional paid-in capital		22,785,154			(22,785,154	)	1		—
Common stock		107,236			(107,236	)	1		—
Net cash provided by financing activities	$	22,892,390			(19,174,380	)		$	3,718,010

Net increase (decrease) in cash and cash equivalents		162,971			(162,971	) 1			—
Cash and cash equivalents, beginning of the period		(32,453	)		32,453				—
Cash and cash equivalents, end of the period	$	130,518			(130,518	) 1		$	—

Supplemental disclosures for cash flow information:
Cash paid during the period for interest	$	—						$	—

Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition	$	—		$	14,778,000	1		$	14,778,000
Reduction of common stock to be issued for acquisition	$	—		$	1,812,769	1		$	1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition	$	—		$	522,659			$	522,659
Issuance of common stock upon conversion of notes payable	$	—		$	3,781,478	1		$	3,781,478
Purchase of intangible assets related to the Cilandro acquisition	$	—		$	158,000	1		$	158,000
Issuance of common stock for intangible assets related to the Cilandro acquisition	$	—		$	110,000	1		$	110,000

REVENUES

9 Months Ended

Jul. 31, 2024

Revenue Recognition and Deferred Revenue [Abstract]

REVENUES

NOTE 4 - REVENUES

Revenues

The decrease in revenue for the nine months ended July 31, 2024 as compared to the same period in a prior year is primarily due to the delay in completions for the specific projects during the year.

●

Service Offerings: Include software subscriptions that require secure access, enabling user interactions via blockchain networks

●

Use Cases: The Company develops tailored solutions, known as Use Cases, which can incorporate both physical inventory and software components. These are customized for each client

●

Cost Sharing: In some instances, the Company co-invests in the initial setup infrastructure costs with government or enterprise partners

●

Revenue Model: Primarily, revenue is derived from subscription fees and transaction fees associated with blockchain interactions, rather than from the initial infrastructure investments.

Disaggregation of Revenue

The following tables provide a disaggregation of revenue by major product line and timing of revenue recognition for the periods presented:

	For the three months ended				For the nine months ended
Product Line	July 31, 2024		July 31, 2023		July 31, 2024		July 31, 2023
BaaP Software Modules	$	—	$	228,518	$	258,320	$	428,518
Consulting and Integration Services		—		—		160,000		150,000
Subscription Services		—		—		110,316		103,772
Total	$	—	$	228,518	$	528,636	$	682,290

ASSETS ACQUSITION

9 Months Ended

Jul. 31, 2024

Receivables [Abstract]

ASSETS ACQUSITION

NOTE 5 – ASSETS ACQUSITION

Core Business Holdings Acquisition

This format adheres to SEC and GAAP guidelines, ensuring that all necessary details concerning the impairment and the related party transaction are comprehensively and transparently reported.

Cilandro SA Acquisition


Consideration
Issuance of common stock	$	110,000
Issuance of convertible note		58,000
Liability assumed		100,000
Total consideration	$	268,000

Asset Acquired
Financial license	$	268,000

CAPITALIZED SOFTWARE DEVELOPMENT COSTS

9 Months Ended

Jul. 31, 2024

Research and Development [Abstract]

CAPITALIZED SOFTWARE DEVELOPMENT COSTS

NOTE 6 - CAPITALIZED SOFTWARE DEVELOPMENT COSTS

● Core Token and Smart Contract Platform: 06/06/2021
● Ping Exchange: 01/22/2021
● Wall Money: 03/13/2021
● Core Pay: 05/14/2019

According to Paragraph 985-20-25-2, CBH had to perform minimum activities as evidence that technological feasibility had been established:

INTANGIBLE ASSETS

9 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

NOTE 7 – INTANGIBLE ASSETS

DEBT

9 Months Ended

Jul. 31, 2024

Debt Disclosure [Abstract]

DEBT

NOTE 8 - DEBT

Convertible Notes Issued in 2024

As of July 31, 2024, the outstanding balance on the remaining notes amounts to $11,000.

Short-Term Borrowings

EQUITY

9 Months Ended

Jul. 31, 2024

Equity [Abstract]

EQUITY

NOTE 9 – EQUITY

Preferred Stock

The Company has authorized 10,000,000 shares of $0.001 par value, preferred stock. As of July 31, 2024 and October 31, 2023 there were 10,000,000 shares of preferred stock issued and outstanding.

Common Stock

2024 Activity

Issuance of common stock in exchange for services performed

During the nine months ended July 31, 2024 the Company issued 611,747 shares of common stock to a consultant for a total of $721,800 recognized as stock compensation.

Reduction of common stock to be issued in connection with acquisition

Issuance of common stock in connection with debt

Issuance of common stock upon conversion of convertible promissory notes

During the nine months ended July 31, 2024 the Company issued 500,342 shares of common stock in connection with the conversion of $404,143 of convertible notes payable (See Note 8).

Issuance of common stock upon settlement of short-term borrowing

2023 Activity

Issuance of common stock in connection with acquisition

During the nine months ended July 31, 2023 the Company issued 2,619,875 shares of common stock in connection with the conversion of $550,285 of convertible notes payable.

Issuance of common stock upon conversion of convertible promissory notes

During the nine months ended July 31, 2023 the Company issued 9,514,525 shares of common stock in connection with the conversion of $3,930,768 of convertible notes payable.

Issuance of common stock in exchange for services performed

During the nine months ended July 31, 2023 the Company issued 2,038,744 shares of common stock to a consultant for a total of $1,959,107 recognized as stock compensation.

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Jul. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

ADVANCES FROM RELATED PARTY

9 Months Ended

Jul. 31, 2024

ADVANCES FROM RELATED PARTY

NOTE 11 – ADVANCES FROM RELATED PARTY

SUBSEQUENT EVENTS

9 Months Ended

Jul. 31, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 12 – SUBSEQUENT EVENTS

In accordance with FASB ASC 855-10, Subsequent Events, the Company has analysed its operations subsequent to July 31, 2024, to the date these financial statements were issued.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Jul. 31, 2024

Accounting Policies [Abstract]

General

General

Arax Holdings Corp. (“the Company”) is a Nevada corporation incorporated on February 23, 2012.

The Company currently has operations from a growing business in the software development and integration marketplace.

Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation

Use of Estimates

Use of Estimates

Cash

Cash

Revenue Recognition

Revenue Recognition

●

Service Offerings: Include software subscriptions that require secure access, enabling user interactions via blockchain networks

●

Use Cases: The Company develops tailored solutions, known as Use Cases, which can incorporate both physical inventory and software components. These are customized for each client

●

Cost Sharing: In some instances, the Company co-invests in the initial setup infrastructure costs with government or enterprise partners

●

Revenue Model: Primarily, revenue is derived from subscription fees and transaction fees associated with blockchain interactions, rather than from the initial infrastructure investments

Contract Assets

Contract Assets

The Company does not have any contract assets. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.

Cost of Revenues

Cost of Revenues

Cost of revenues consists of employee costs, third party staffing costs and other fees, outsourced recruiter fees, and commissions. There have been no costs of revenue for the periods presented.

Accounts Receivable

Accounts Receivable

Property and Equipment

Property and Equipment

Concentration of Credit Risk and Significant Customers and Vendors

Concentration of Credit Risk and Significant Customers and Vendors

As of July 31, 2024, and October 31, 2023 one customer accounted for all of the accounts receivable balance.

Research and Development

Research and Development

Advertising and Marketing Costs

Advertising and Marketing Costs

The Company expenses all advertising and marketing costs as incurred. Advertising and marketing costs were not material for the three and nine months ended July 31, 2024 and 2023, respectively.

Fair Value of Financial Instruments and Fair Value Measurements

Fair Value of Financial Instruments and Fair Value Measurements

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.


Ending balance, October 31, 2022	$	—
Initial recognition of derivative liability:		1,047,879
Re-measurement adjustments:
Change in fair value of derivative liability		(1,047,879	)
Ending balance, July 31, 2023	$	—

The fair value of the derivative liability was estimated using binomial option-pricing model with the following assumptions:

	July 31, 2023
Stock Price on Valuation Date	$	0.70
Risk-Free Rate		5.53	%
Volatility		307.56	%
Term		2.5 yrs
Conversion price	$	0.2

Business Combinations

Business Combinations

Intangible Assets

Intangible Assets

Long-lived Assets

Long-lived Assets

Software Development Costs

Software Development Costs

Related Party Transactions

Related Party Transactions

The Company considers all officers, directors, senior management personnel, and senior level consultants to be related parties to the Company.

Income Taxes

Income Taxes

Stock-Based Compensation

Stock-Based Compensation

Derivative Liabilities

Derivative Liabilities

Convertible Instruments

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.

ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.

Leases

Leases

Loss per Share

Loss per Share

Schedule of earnings per share

	July 31, 2024		July 31, 2023
Convertible notes	$	42,211	$	—
Convertible preferred stock		1,000,000		1,000,000
Total	$	1,042,211	$	1,000,000

Business Segments

Business Segments

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Jul. 31, 2024

Accounting Policies [Abstract]

Schedule of fair value on a recurring basis


Ending balance, October 31, 2022	$	—
Initial recognition of derivative liability:		1,047,879
Re-measurement adjustments:
Change in fair value of derivative liability		(1,047,879	)
Ending balance, July 31, 2023	$	—

The fair value of the derivative liability was estimated using binomial option-pricing model with the following assumptions:

	July 31, 2023
Stock Price on Valuation Date	$	0.70
Risk-Free Rate		5.53	%
Volatility		307.56	%
Term		2.5 yrs
Conversion price	$	0.2

Schedule of earnings per share

	July 31, 2024		July 31, 2023
Convertible notes	$	42,211	$	—
Convertible preferred stock		1,000,000		1,000,000
Total	$	1,042,211	$	1,000,000

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)

9 Months Ended

Jul. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]


	For the Three Months Ended										For the Nine Months Ended
	July 31,							July 31,			July 31,							July 31,
	2023			Adjustments				2023			2023			Adjustments				2023
	(As Filed)							(As Restated)			(As Filed)							(As Restated)
Revenues	$	228,518		$	—			$	228,518		$	682,290		$	—			$	682,290
Cost of sales		—			—				—			—			—				—
Gross profit (loss)		228,518			—				228,518			682,290			—				682,290

Operating expenses:
General and administrative expenses		379,295			2,457,265		2,4		2,836,560			831,237			3,022,676		2,4		3,853,913
Development expenses		2,185,420			(2,185,420	)	5		—			3,154,142			(3,154,142	)	5		—
Stock based compensation		—			448,430		3		448,430			—			1,959,107		3		1,959,107
Total operating expenses		2,564,715			720,275				3,284,990			3,985,379			1,827,641				5,813,020

Loss from operations		(2,336,197	)		(720,275	)			(3,056,472	)		(3,303,089	)		(1,827,641	)			(5,130,730	)

Other income (expense):
Other income (expense)		334,743			—				334,743			(750	)		—				(750	)
Total other income (expense)		334,743			—				334,743			(750	)		—				(750	)

Net loss before taxes		(2,001,454	)		(720,275	)			(2,721,729	)		(3,303,839	)		(1,827,641	)			(5,131,480	)
Income tax provision (benefit)		—			—				—			—			—				—
Net loss	$	(2,001,454	)	$	(720,275	)		$	(2,721,729	)	$	(3,303,839	)	$	(1,827,641	)		$	(5,131,480	)

Net loss per share, basic and diluted	$	(0.04	)	$				$	(0.02	)	$	(0.06	)	$				$	(0.10	)
Weighted average shares outstanding, basic and diluted		51,295,583							114,065,825			51,295,583							50,007,263


	For the nine months ended July 31, 2023			Adjustments				For the nine months ended July 31, 2023
	(As Filed)							(As Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,303,839	)		(1,827,641	) 1		$	(5,131,480	)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock		—			1,959,095		1		1,959,095
Amortization of debt discount related to derivatives		—			1,047,879		1		1,047,879
Change in fair value of derivative liability		—			(1,047,879	)	1		(1,047,879	)
Changes in operating assets and liabilities
Increase in accounts receivable		(680,658	)		—				(680,658	)
Increase in accounts payable and accrued liabilities		73,363			61,670		1		135,033
Net cash used in operating activities	$	(3,911,134	)		193,124			$	(3,718,010	)

CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments		(18,818,285	)		18,818,285		1		—
Net cash used in investing activities	$	(18,818,285	)		18,818,285			$	—

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		—			3,718,010		1		3,718,010
Additional paid-in capital		22,785,154			(22,785,154	)	1		—
Common stock		107,236			(107,236	)	1		—
Net cash provided by financing activities	$	22,892,390			(19,174,380	)		$	3,718,010

Net increase (decrease) in cash and cash equivalents		162,971			(162,971	) 1			—
Cash and cash equivalents, beginning of the period		(32,453	)		32,453				—
Cash and cash equivalents, end of the period	$	130,518			(130,518	) 1		$	—

Supplemental disclosures for cash flow information:
Cash paid during the period for interest	$	—						$	—

Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition	$	—		$	14,778,000	1		$	14,778,000
Reduction of common stock to be issued for acquisition	$	—		$	1,812,769	1		$	1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition	$	—		$	522,659			$	522,659
Issuance of common stock upon conversion of notes payable	$	—		$	3,781,478	1		$	3,781,478
Purchase of intangible assets related to the Cilandro acquisition	$	—		$	158,000	1		$	158,000
Issuance of common stock for intangible assets related to the Cilandro acquisition	$	—		$	110,000	1		$	110,000

REVENUES (Tables)

9 Months Ended

Jul. 31, 2024

Revenue Recognition and Deferred Revenue [Abstract]

The following tables provide a disaggregation of revenue by major product line and timing of revenue recognition for the periods presented:

	For the three months ended				For the nine months ended
Product Line	July 31, 2024		July 31, 2023		July 31, 2024		July 31, 2023
BaaP Software Modules	$	—	$	228,518	$	258,320	$	428,518
Consulting and Integration Services		—		—		160,000		150,000
Subscription Services		—		—		110,316		103,772
Total	$	—	$	228,518	$	528,636	$	682,290

ASSETS ACQUSITION (Tables)

9 Months Ended

Jul. 31, 2024

Receivables [Abstract]

Schedule of assets acquisition


Consideration
Issuance of common stock	$	110,000
Issuance of convertible note		58,000
Liability assumed		100,000
Total consideration	$	268,000

Asset Acquired
Financial license	$	268,000

Schedule of fair value on a recurring basis (Details)	9 Months Ended
Schedule of fair value on a recurring basis (Details)	Jul. 31, 2023 USD ($)
Accounting Policies [Abstract]
Ending balance, October 31, 2022
Initial recognition of derivative liability:	1,047,879
Re-measurement adjustments:
Change in fair value of derivative liability	(1,047,879)
Ending balance, July 31, 2023

The fair value of the derivative liability was estimated using binomial option-pricing model with the following assumptions: (Details)	Jul. 31, 2023 $ / shares
Accounting Policies [Abstract]
Stock Price on Valuation Date	$ 0.70
Risk-Free Rate	5.53%
Volatility	$ 307.56
Term	2 years 6 months
Conversion price	$ 0.2

Schedule of earnings per share (Details) - USD ($)	Jul. 31, 2024	Jul. 31, 2023
Accounting Policies [Abstract]
Convertible notes	$ 42,211
Convertible preferred stock	1,000,000	1,000,000
Total	$ 1,042,211	$ 1,000,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Entity incorporation, state or country code			NV
Cash equivalents	$ 0		$ 0
Depreciation expense	$ 151		$ 453
Antidilutive securities excluded			1,042,211	1,000,000
Arax Holdings Corp Member
Entity incorporation, state or country code			NV
Entity incorporation date			Feb. 23, 2012

The following table sets forth the effects of the adjustments on affected items within the Company’s previously reported condensed consolidated statement of operations for the three and nine months ended July 31, 2023: (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenues		$ 228,518	$ 528,636	$ 682,290
Cost of sales
Gross profit (loss)		228,518	528,636	682,290
Operating expenses:
General and administrative expenses	329,765	2,836,560	608,904	3,853,913
Total Operating Expenses	329,765	2,836,560	1,330,765	5,813,020
LOSS FROM OPERATIONS	(329,765)	(2,608,042)	(802,129)	(5,130,730)
Other income (expense):
Total other income (expense)	(103,501)	334,743	(103,803)	(750)
Net loss before taxes	(433,266)	(2,273,299)	(905,932)	(5,131,480)
Income tax provision (benefit)
Net loss	$ (433,266)	$ (2,273,299)	$ (905,932)	$ (5,131,480)
Net loss per share, basic and diluted	$ (0.00)	$ (0.02)	$ (0.01)	$ (0.10)
Weighted average shares outstanding, basic and diluted	128,066,699	114,065,825	127,256,650	50,007,263
Previously Reported [Member]
Revenues		$ 228,518		$ 682,290
Cost of sales
Gross profit (loss)		228,518		682,290
Operating expenses:
General and administrative expenses		379,295		831,237
Development expenses		2,185,420		3,154,142
Stock based compensation
Total Operating Expenses		2,564,715		3,985,379
LOSS FROM OPERATIONS		(2,336,197)		(3,303,089)
Other income (expense):
Other income (expense)		334,743		(750)
Total other income (expense)		334,743		(750)
Net loss before taxes		(2,001,454)		(3,303,839)
Income tax provision (benefit)
Net loss		$ (2,001,454)		$ (3,303,839)
Net loss per share, basic and diluted		$ (0.04)		$ (0.06)
Weighted average shares outstanding, basic and diluted		51,295,583		51,295,583
Revision of Prior Period, Adjustment [Member]
Revenues
Cost of sales
Gross profit (loss)
Operating expenses:
General and administrative expenses		2,457,265		3,022,676
Development expenses		(2,185,420)		(3,154,142)
Stock based compensation		448,430		1,959,107
Total Operating Expenses		720,275		1,827,641
LOSS FROM OPERATIONS		(720,275)		(1,827,641)
Other income (expense):
Other income (expense)
Total other income (expense)
Net loss before taxes		(720,275)		(1,827,641)
Income tax provision (benefit)
Net loss		(720,275)		(1,827,641)
As Restated [Member]
Revenues		228,518		682,290
Cost of sales
Gross profit (loss)		228,518		682,290
Operating expenses:
General and administrative expenses		2,836,560		3,853,913
Development expenses
Stock based compensation		448,430		1,959,107
Total Operating Expenses		3,284,990		5,813,020
LOSS FROM OPERATIONS		(3,056,472)		(5,130,730)
Other income (expense):
Other income (expense)		334,743		(750)
Total other income (expense)		334,743		(750)
Net loss before taxes		(2,721,729)		(5,131,480)
Income tax provision (benefit)
Net loss		$ (2,721,729)		$ (5,131,480)
Net loss per share, basic and diluted		$ (0.02)		$ (0.10)
Weighted average shares outstanding, basic and diluted		114,065,825		50,007,263

The following table sets forth the effects of the adjustments on affected items within the Company’s previously reported consolidated statements of cash flows for the nine months ended July 31, 2023: (Details) - USD ($)	9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (905,932)	$ (5,131,480)
Changes in operating assets and liabilities
Increase in accounts receivable	(528,636)	(680,658)
Increase in accounts payable and accrued liabilities	138,496	135,033
Net cash used in operating activities	(469,980)	(3,718,010)
CASH FLOWS FROM INVESTING ACTIVITIES
Net cash used in investing activities	(1,372,620)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	362,000	3,718,010
Common stock	110,000
Net cash provided by financing activities	406,000	3,718,010
Net decrease in cash and cash equivalents	(1,436,600)
Cash and cash equivalents, beginning of the period	1,448,769
Cash and cash equivalents, end of the period	12,169
Supplemental disclosures for cash flow information:
Cash paid during the period for interest
Supplemental disclosure of noncash financing activities:
Issuance of common stock for intangible assets related to the Cilandro acquisition		110,000
Previously Reported [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss		(3,303,839)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock
Amortization of debt discount related to derivatives
Change in fair value of derivative liability
Changes in operating assets and liabilities
Increase in accounts receivable		(680,658)
Increase in accounts payable and accrued liabilities		73,363
Net cash used in operating activities		(3,911,134)
CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments		(18,818,285)
Net cash used in investing activities		(18,818,285)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable
Additional paid-in capital		22,785,154
Common stock		107,236
Net cash provided by financing activities		22,892,390
Net decrease in cash and cash equivalents		162,971
Cash and cash equivalents, beginning of the period		(32,453)
Cash and cash equivalents, end of the period		130,518
Supplemental disclosures for cash flow information:
Cash paid during the period for interest
Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition
Reduction of common stock to be issued for acquisition
Issuance of common stock in the conversion of convertible notes related to the acquisition
Issuance of common stock upon conversion of notes payable
Purchase of intangible assets related to the Cilandro acquisition
Issuance of common stock for intangible assets related to the Cilandro acquisition
Revision of Prior Period, Adjustment [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss		(1,827,641)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock		1,959,095
Amortization of debt discount related to derivatives		1,047,879
Change in fair value of derivative liability		(1,047,879)
Changes in operating assets and liabilities
Increase in accounts receivable
Increase in accounts payable and accrued liabilities		61,670
Net cash used in operating activities		193,124
CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments		18,818,285
Net cash used in investing activities		18,818,285
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		3,718,010
Additional paid-in capital		(22,785,154)
Common stock		(107,236)
Net cash provided by financing activities		(19,174,380)
Net decrease in cash and cash equivalents		(162,971)
Cash and cash equivalents, beginning of the period		32,453
Cash and cash equivalents, end of the period		(130,518)
Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition		14,778,000
Reduction of common stock to be issued for acquisition		1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition		522,659
Issuance of common stock upon conversion of notes payable		3,781,478
Purchase of intangible assets related to the Cilandro acquisition		158,000
Issuance of common stock for intangible assets related to the Cilandro acquisition		110,000
As Restated [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss		(5,131,480)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity based compensation expense - stock		1,959,095
Amortization of debt discount related to derivatives		1,047,879
Change in fair value of derivative liability		(1,047,879)
Changes in operating assets and liabilities
Increase in accounts receivable		(680,658)
Increase in accounts payable and accrued liabilities		135,033
Net cash used in operating activities		(3,718,010)
CASH FLOWS FROM INVESTING ACTIVITIES
Long term investments
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable		3,718,010
Additional paid-in capital
Common stock
Net cash provided by financing activities		3,718,010
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of the period
Cash and cash equivalents, end of the period
Supplemental disclosures for cash flow information:
Cash paid during the period for interest
Supplemental disclosure of noncash financing activities:
Issuance of common stock for acquisition		14,778,000
Reduction of common stock to be issued for acquisition		1,812,769
Issuance of common stock in the conversion of convertible notes related to the acquisition		522,659
Issuance of common stock upon conversion of notes payable		3,781,478
Purchase of intangible assets related to the Cilandro acquisition		158,000
Issuance of common stock for intangible assets related to the Cilandro acquisition		$ 110,000

GOING CONCERN (Details Narrative) $ in Thousands	Jul. 31, 2024 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 470
Working capital deficit	$ 261

The following tables provide a disaggregation of revenue by major product line and timing of revenue recognition for the periods presented: (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenues		$ 228,518	$ 528,636	$ 682,290
Baa P Software Modules Member
Revenues		228,518	258,320	428,518
Consulting And Integration Services Member
Revenues			160,000	150,000
Subscription Services Member
Revenues			$ 110,316	$ 103,772

REVENUES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
REVENUES (Details Narrative) - USD ($)	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenues				$ 682,290
Arax Holdings Corp Member
Revenues		$ 228,518	$ 528,636

Schedule of assets acquisition (Details)	9 Months Ended
Schedule of assets acquisition (Details)	Jul. 31, 2024 USD ($)
Receivables [Abstract]
Issuance of common stock	$ 110,000
Issuance of convertible note	58,000
Liability assumed	100,000
Total consideration	268,000
Financial license	$ 268,000

ASSETS ACQUSITION (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	9 Months Ended
ASSETS ACQUSITION (Details Narrative) - USD ($)	May 03, 2023	Dec. 31, 2022	Jul. 31, 2024	Jul. 31, 2024	Oct. 31, 2023
Impairment recognized			$ 18,550,285	$ 18,550,285
Number of shares, issued			128,253,557	128,253,557	126,160,534
Principal, amount			$ 267,000	$ 362,000
Cilandro S A Acquisition Member
Percentage of acquired	100.00%
Number of shares, issued	110,000
Principal, amount	$ 58,000
Accrued liability	100,000
Aggregate purchase price	$ 268,000
Arax Holdings Corp Member
Intellectual properties, value		$ 18,000,000
Arax Holdings Corp Member \| Intellectual Property [Member]
Intellectual properties, value		$ 18,000,000

CAPITALIZED SOFTWARE DEVELOPMENT COSTS (Details Narrative) - USD ($)	Jul. 31, 2024	Oct. 31, 2023
Research and Development [Abstract]
Software development costs	$ 6,405,952	$ 5,033,332

INTANGIBLE ASSETS (Details Narrative) - USD ($)	Jul. 31, 2024	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Indefinite lived intangible assets	$ 268,000	$ 268,000

DEBT (Details Narrative) - USD ($)		3 Months Ended	9 Months Ended
DEBT (Details Narrative) - USD ($)	May 10, 2024	Jul. 31, 2024	Jul. 31, 2024
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible promissory note agreement		$ 267,000	$ 362,000
Unpaid principal balance rate			10.00%
Outstanding Notes Amount		11,000	$ 11,000
Short-Term Debt	$ 44,000
Settelment Of Outstanding Common Shares One	110,000
Stock Price one	$ 1.34
Short Term Borrowing Loss On Extinguishment		$ 103,400
Measurement Input, Conversion Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion, description			After two days from the effective date of each respective note, each noteholder shall have the right at any time to convert the outstanding principal in whole or in part into shares of common stock. For the first 60 days following the execution of the agreement, the conversion price shall be equal to a range from $0.55 to $0.80 for each common share, identified in each individual note agreement. After 60 days following the execution of the agreement, the conversion price will be 80% of the average of the lowest three closing prices of the Company’s common stock during the 10 consecutive trading days prior to the date the Holder elects to convert all or part of the note.
Note HolderFive Member
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion, description		the Company issued a grand total of 390,342 shares of common stock at conversion rates between $0.55 and $0.80 for total consideration of approximately $256,743.	the Company issued a grand total of 555,051 shares of common stock at conversion rates between $0.55 and $0.80 for total consideration of approximately $352,173.
Stock Issued During Period, Shares, Conversion of Convertible Securities		390,342	555,051

EQUITY (Details Narrative) - USD ($)			3 Months Ended				9 Months Ended
EQUITY (Details Narrative) - USD ($)	May 10, 2024	Mar. 31, 2021	Jul. 31, 2024	Jan. 31, 2024	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2024	Jul. 31, 2023	Jul. 30, 2023	Apr. 30, 2024	Oct. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Notes Payable							$ 362,000	$ 3,718,010
Repayments of debt		$ 16,166
Share-Based Compensation		$ 83,834					$ 721,862	1,959,095
Common stock, shares authorized			950,000,000				950,000,000				950,000,000
Common Stock, par value (in dollars per share)			$ 0.0001				$ 0.0001				$ 0.0001
Common stock, shares, outstanding			128,253,557				128,253,557				126,160,534
Common stock, shares, issued			128,253,557				128,253,557				126,160,534
Stock Issued During Period, Value, Issued for Services				$ 721,862		$ 1,959,108
Stock Issued During Period, Value, Acquisitions						18,000,000
Equity Convertible Notes Payable			$ 95,000				$ 95,000
Promissory Notes Stock Issued			$ 404,143				$ 404,143
Settelment Of Outstanding Common Shares	110,000
Stock Price	$ 1.34
Stock Issued During Period Value Convertible Notes Payable								550,285
Promissory Notes Stocks Issued								$ 3,930,768
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			10,000,000				10,000,000				10,000,000
Preferred stock, par value (in dollars per share)		$ 0.001	$ 0.001				$ 0.001				$ 0.001
Preferred stock, shares outstanding			10,000,000				10,000,000				10,000,000
Preferred stock, shares issued		10,000,000	10,000,000				10,000,000				10,000,000
Series A Preferred Stock [Member] \| Related Party Transactions Member
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Conversion Basis		10 for 1
Proceeds from Notes Payable		$ 16,166
Common Stock Issued For Loan And Compensation Expenses		$ 100,000
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			10,000,000				10,000,000				10,000,000
Preferred stock, par value (in dollars per share)			$ 0.001				$ 0.001				$ 0.001
Preferred stock, shares outstanding			10,000,000				10,000,000				10,000,000
Preferred stock, shares issued			10,000,000				10,000,000				10,000,000
Stock Issued During Period, Value, Issued for Services
Stock Issued During Period, Value, Acquisitions
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized										950,000,000
Common Stock, par value (in dollars per share)										$ 0.0001
Common stock, shares, outstanding			128,253,557				128,253,557				126,160,534
Common stock, shares, issued			128,253,557				128,253,557				126,160,534
Stock Issued During Period, Shares, Issued for Services				611,747		2,038,744	611,747	2,038,744
Stock Issued During Period, Value, Issued for Services				$ 62		$ 204	$ 721,800	$ 1,959,107
Stock Issued During Period, Shares, Acquisitions			2,847,381			90,215,096	816,225	90,215,096
Stock Issued During Period, Value, Acquisitions					285	$ 9,022	$ 540,000		$ 1,812,769
Stock Issued During Period Shares Connection Debt							164,709
Common Stock Convertible Promissory Notes							500,342	9,514,525
Additional Share To Be Issued					3,222,000			$ 3,222,000
Total Shares Acquisitions					$ 18,000,000			$ 18,000,000
Stock Issued During Period Conversion Shares Acquisitions								2,619,875
Common Stock [Member] \| Core Business Holdings [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock Issued During Period, Shares, Acquisitions								2,847,381